AnPac Bio-Medical Science
We are a biotechnology company focusing on early cancer screening and detection. We market and sell a multi-cancer screening and detection test that uses our innovative, patented cancer differentiation analysis, or CDA, technology and our proprietary cancer-detection device, or CDA device.
$12.00 - $14.00
January 30, 2020
WESTPARK CAPITAL, INC.
This offering is no longer available
Sign Up to participate in future offerings
To view the prospectus for AnPac Bio-Medical Science IPO, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277